EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment

Submitted by admin on June 23, 2023 - 9:51am

Source:

Benzinga

News Tags:

Amylyx Pharmaceuticals

ALS

Albrioza

EMA

Europe

Headline:

EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment

snippet:

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion regarding Amylyx Pharmaceuticals Inc's AMLX conditional marketing authorization of AMX0035 (Albrioza) for amyotrophic lateral sclerosis (ALS).

Search form

You are here

EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment

EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment